Search company, investor...

Total Raised

$483.64M

Investors Count

11

Deal Terms

3

Funding, Valuation & Revenue

9 Fundings

Reify Health has raised $483.64M over 9 rounds.

Reify Health's latest funding round was a Series D for $220M on April 21, 2022.

Reify Health's valuation in August 2021 was $2,200M.

Reify Health's latest post-money valuation is from April 2022.

Sign up for a free demo to see Reify Health's valuations in April 2022 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

4/21/2022

Series D

$220M

$XXM

0

FY undefined

5

8/10/2021

Series C

$XXM

$2,200M

0

FY undefined

10

8/12/2020

Series B

$XXM

$XXM

0

FY undefined

10

12/24/2018

Series A - II

$XXM

$XXM

0

FY undefined

0

1/1/2018

Series A

$XXM

$XXM

0

FY undefined

10

Date

4/21/2022

8/10/2021

8/12/2020

12/24/2018

1/1/2018

Round

Series D

Series C

Series B

Series A - II

Series A

Amount

$220M

$XXM

$XXM

$XXM

$XXM

Investors

Valuation

$XXM

$2,200M

$XXM

$XXM

$XXM

Revenue

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

0

FY undefined

Sources

5

10

10

0

10

You're one click away from the most comprehensive, unmatched analyst expertise in tech, in-depth private company data and a platform that brings it all together.
Click Now. Join a live demo
Join a demo
CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Reify Health Deal Terms

3 Deal Terms

Reify Health's deal structure is available for 3 funding rounds, including their Series D from April 21, 2022.

Round

Series D

Series C

Convertible Note

Funding Date

$XXM

$XXM

$XXM

Pre-Money Valuation

$XXM

$XXM

$XXM

Post-Money Valuation

$XXM

$XXM

$XXM

Amount Raised

$XXM

$XXM

$XXM

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

$XXM

$XXM

$XXM

Board Voting

$XXM

$XXM

$XXM

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Series D

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Series C

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Convertible Note

$XXM

$XXM

$XXM

$XXM

$XXM

$XXM

Reify Health Investors

11 Investors

Reify Health has 11 investors. Battery Ventures invested in Reify Health's Series D funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/12/2020

4/21/2022

3
Series B, Series C (2021), Series D (2022)

Venture Capital

Massachusetts

8/10/2021

4/21/2022

2
Series C, Series D (2022)

Private Equity

Illinois

8/10/2021

4/21/2022

2
Series C, Series D (2022)

Hedge Fund

New York

00/00/0000

00/00/0000

ICONIQ Growth

Subscribe to see more

Private Equity

California

00/00/0000

00/00/0000

Altimeter Capital

Subscribe to see more

Asset/Investment Management

Massachusetts

First funding

8/12/2020

8/10/2021

8/10/2021

00/00/0000

00/00/0000

Last Funding

4/21/2022

4/21/2022

4/21/2022

00/00/0000

00/00/0000

Investor

ICONIQ Growth

Altimeter Capital

Rounds

3
Series B, Series C (2021), Series D (2022)
2
Series C, Series D (2022)
2
Series C, Series D (2022)

Subscribe to see more

Subscribe to see more

Board Seats

Type

Venture Capital

Private Equity

Hedge Fund

Private Equity

Asset/Investment Management

Location

Massachusetts

Illinois

New York

California

Massachusetts

CB Insights
Looking for a leg up on competitive, customer and technology insights?
CB Insights puts confidence and clarity into your most strategic decisions.
See how. Join a demo.
Join a demo
Trusted by the world's smartest companies to:
  • Predict emerging trends
  • See competitors' playbooks
  • Stalk the smart money
  • Identify tomorrow's challengers
  • Spot growing industries
  • Kill analyst data work
Let's see how we can help you!
MicrosoftWalmartWells Fargo

Compare Reify Health to Competitors

Medable Logo
Medable

Medable specializes in providing digital clinical trial software solutions within the healthcare and pharmaceutical sectors. The company offers a comprehensive platform that facilitates the management of clinical trials, including tools for remote data collection, electronic consent (eConsent), patient-reported outcomes (ePRO), and clinical outcome assessments (eCOA), all designed to streamline the trial process and enhance data quality. Medable was formerly known as Dermatrap. It was founded in 2012 and is based in Palo Alto, California.

Curebase Logo
Curebase

Curebase provides a range of software tools designed for clinical trial recruitment, consent, and data collection processes. Curebase primarily serves the clinical research industry, including CROs, research sites, and study participants. The company was founded in 2017 and is based in San Francisco, California.

THREAD Logo
THREAD

THREAD is a company that focuses on providing a decentralized clinical trial platform in the healthcare and life sciences industry. The company offers a platform and supporting services that enable biopharma, CROs, and life science organizations to remotely capture data from participants and sites during, in-between, and in lieu of in-clinic visits. The platform includes features such as electronic consent (eConsent), electronic clinical outcome assessment (eCOA), sensors, reminders, and telehealth virtual visits. It was founded in 2005 and is based in Tustin, California.

Hawthorne Effect Logo
Hawthorne Effect

Hawthorne Effect specializes in providing mobile, tech-driven solutions for clinical trials within the healthcare sector. The company offers a platform that facilitates mobile clinical trial visits, enhances patient access, and ensures high-quality data collection through a network of healthcare professionals. Hawthorne Effect primarily serves the biopharma, medtech, and healthcare industries by improving clinical trial efficiency, data quality, and patient diversity. It was founded in 2015 and is based in Lafayette, California.

Formation Bio Logo
Formation Bio

Formation Bio is a tech-driven, AI-native pharmaceutical company focused on drug development. The company specializes in acquiring and developing clinical-stage drugs more efficiently by leveraging a proprietary technology platform that incorporates artificial intelligence. Formation Bio primarily serves the pharmaceutical industry by expediting the drug development process for various therapeutic areas. It was formerly known as TrialSpark. It was founded in 2013 and is based in New York, New York.

BloqCube Logo
BloqCube

BloqCube is a software company specializing in decentralized clinical trial management and financial systems. The company offers an integrated Clinical Trial Management & Financial System (CTMFS) platform designed to accelerate Decentralized Clinical Trials (DCT) by providing a secure, transparent, and efficient way to manage trials and handle financial transactions. BloqCube primarily serves the healthcare and pharmaceutical sectors by streamlining clinical trial processes and financial management. It was founded in 2017 and is based in Piscataway, New Jersey.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.